Company Filing History:
Years Active: 1995
Title: Michael J Geisow: Innovator in Plasma Expanding Agents
Introduction
Michael J Geisow is a notable inventor based in Bingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that serve as plasma expanding agents. His innovative work has the potential to impact medical treatments for burns and shock in humans.
Latest Patents
Geisow holds a patent for "Truncated human serum albumin polypeptides as plasma expanding agents." This patent describes polypeptides corresponding to mature human serum albumin residues 1 to n, where n is between 369 and 419 inclusive. These polypeptides are useful as substitutes for albumin in various medical applications, including the treatment of burns and shock, the clearance of undesirable compounds such as bilirubin from human blood, and in laboratory growth media and HSA assays. The polypeptides can be produced using recombinant DNA techniques, particularly in yeast.
Career Highlights
Michael J Geisow is associated with Delta Biotechnology Limited, where he continues to advance his research and development efforts. His work in the field of biotechnology has garnered attention for its innovative approach to addressing critical medical needs.
Collaborations
Geisow has collaborated with notable colleagues, including David J Ballance and Edward Hinchliffe. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Michael J Geisow's contributions to the field of biotechnology, particularly through his patent on plasma expanding agents, highlight his role as an innovator. His work has the potential to significantly improve medical treatments and outcomes for patients.